Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

China

China Articles

Industry

BMI View: We maintain our positive outlook for the Chinese pharmaceutical market in 2013. Domestic pharmaceutical firms achieved strong revenue growth in 2012, in line with our bullish... 2013-04-09


Industry

BMI View: The expansion of China's National Essential Drug List (NEDL) is good news for patients and their families, as it will boost healthcare access and increase affordability of... 2013-03-22


Industry

BMI View: Despite calls for the termination of the drug tendering system in China, we believe the government's focus on cost containment within the pharmaceuticals and healthcare sector,... 2013-03-11


More ARTICLES

Industry

BMI View: We view China's aim of creating a single food and drug regulatory body as positive for both domestic and multinationalpharmaceutical firms. Such an institution will work to... 2013-03-06


Industry

BMI View: In general, China remains the key emerging market for multinational pharmaceutical firms, given their strong double-digit sales growth. In particular, Q412 was a milestone... 2013-02-25


Industry

BMI View: China's large and ageing population will continue to drive pharmaceutical and healthcare expenditure. A further source of growth comes from the government's commitment to... 2013-02-21


Industry

BMI View: Pharmaceutical companies will increasingly partner with manufacturers of traditional medicines. These partnerships have two purposes. The first is to gain a greater understanding... 2013-02-18


Finance

Earlier this week, we identified an exit strategy for our long-held bullish view towards Chinese pharmaceutical distributor Sinopharm given a deteriorating technical picture, with HKD24.00... 2013-01-31